Dr. Charity I Oyedeji, MD
Claim this profileDuke University
Studies Sickle Cell Disease
1 reported clinical trial
1 drug studied
Affiliated Hospitals
Clinical Trials Charity I Oyedeji, MD is currently running
More about Charity I Oyedeji, MD
Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Charity I Oyedeji, MD has experience with
- Gerofit Exercise Program
Breakdown of trials Charity I Oyedeji, MD has run
Sickle Cell Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Charity I Oyedeji, MD specialize in?
Charity I Oyedeji, MD focuses on Sickle Cell Disease and other conditions. In particular, much of their work with Sickle Cell Disease has involved treating patients, or patients who are undergoing treatment.
Is Charity I Oyedeji, MD currently recruiting for clinical trials?
Yes, Charity I Oyedeji, MD is currently recruiting for 1 clinical trial in Durham North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Charity I Oyedeji, MD has studied deeply?
Yes, Charity I Oyedeji, MD has studied treatments such as Gerofit Exercise Program.
What is the best way to schedule an appointment with Charity I Oyedeji, MD?
Apply for one of the trials that Charity I Oyedeji, MD is conducting.
What is the office address of Charity I Oyedeji, MD?
The office of Charity I Oyedeji, MD is located at: Duke University, Durham, North Carolina 27710 United States. This is the address for their practice at the Duke University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.